Clinical Trial Imaging Market (COVID - 19 Updates) 2020 to See Stunning Growth Worldwide, Leading Players -BioTelemetry, Inc, IXICO plc, Resonance Health, Bioclinica, ICON plc, Radiant Sage LLC, Lyscaut Medical Imaging Company

This Global Clinical Trial Imaging Market​​​​​​​ research report is a sure solution to get market insights with which you can visualize market place clearly and thereby take important decisions for growth of your business. By getting an inspiration from the marketing strategies of rivals, businesses can set up inventive ideas and striking sales targets which in turn make them achieve competitive advantage over its competitors. Global Clinical Trial Imaging Market​​​​​​​ report inspects the market with respect to general market conditions, market improvement, market scenarios, development, cost and profit of the specified market regions, position and comparative pricing between major players.

Global Clinical Trial Imaging Market is projected to register a substantial CAGR of 6.7% in the forecast period of 2019 to 2026. The new market report contains data for the historic year 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2026.

Download FREE Sample (350 Pages PDF) Report: To Know the Impact of COVID-19 on this Industry@
https://www.databridgemarketresearch.com/covid-19-impact/global-clinical-trial-imaging-market?pm

Market Trends:

Global clinical trial imaging market is segmented into five notable segments which are basis of product & services, modality, application, end user and distribution channel.

On the basis of product & services, the market is segmented into services and software. Services segment is expected to dominate because it provides accurate data and consulting to pharma and biotech companies about the particular clinical trial which is beneficial for the companies to launch new molecules.
On the basis of modality, the market is segmented computed tomography, magnetic resonance imaging, echocardiography, nuclear medicine, positron emission tomography, X-ray, ultrasound, optical coherence tomography and others. Computed tomography segment is expected to dominate due to the rising number of chronic diseases.
On the basis of application, the market is segmented oncology, neurology, endocrinology, cardiology, dermatology, hematology and others
On the basis of end user, the market is segmented into pharmaceutical & biotechnology companies, contract research organizations, academic and government research institutes, medical device manufacturers and others
On the basis of distribution channel, the market is segmented into direct sales and tender sales

Drivers: Global Clinical Trial Imaging Market​​​​​​​

Rising R&D expenditure
Increasing number of contract research organization

Restraints:

High risk radiation causing diseases
High implementation cost of imaging system

Opportunity:

Strategic initiatives for business expansion

Challenge:

Strict regulatory policies

Major Players: Global Clinical Trial Imaging Market​​​​​​​

Some of the major players operating in this market are BioTelemetry, Inc, IXICO plc, Resonance Health, Bioclinica, ICON plc, Radiant Sage LLC, Lyscaut Medical Imaging Company, Quotient Sciences, worldcare Clinical, Navitas Life Sciences, Cardiovascular Imaging Technologies, Intrinsic Imaging, Image Core Lab, ERT Clinical, Perspectum Diagnostics, Anagram 4 clinical trials, Parexel International Corporation among others.

Buy this Report (Can be used by entire organization across the globe + Downloadable and Printable PDF + 30 + Countries) @
https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-clinical-trial-imaging-market&pm

The clinical trial imaging business is anticipated to augment business germination in the projection period of 2019 to 2026 reckoning to USD 611.90 million by 2026 expanding at an annual growth of 6.9% in the above-mentioned projection years. North America clinical trial imaging market is growing with factors such as increasing number of contract research organization, rising R&D expenditure and increasing prevalence of chronic diseases. However, high risk radiation causing diseases and high implementation cost of imaging systems are some of the factors that are acting as restraints and may obstruct the growth of the market in the given forecast period.

North America Clinical Trial Imaging Market Scenario             

According to Data Bridge Market Research, the market for clinical trial imaging in the U.S. has the highest market share followed by Canada & Mexico. Market leader is Navitas Life Sciences which accounts an estimated market share of approximately 34.40% in the North America. The company has gained outstanding sales through providing clinical trial imaging services.

For instance,

In January 2019, Resonance Health announced that they have entered into an agreement with EnvoyAI to distribute its FerriSmart product in the U.S. market, the product have received FDA regulatory clearance. After this agreement the company has expanded their business in the U.S. market.

Trends Impacting the Market

Now the question is which other regions Navitas Life Sciences, BioTelemetry, Inc, RESONANCE HEALTH, IXICO plc, ICON plc are targeting? Data Bridge Market Research has estimated a large share in North America clinical trial imaging market and the market leaders targeting the U.S., Mexico, and Canada to be their next revenue pockets for 2019.

Clinical trial imaging market is becoming more competitive with companies such as Navitas Life Sciences, BioTelemetry, Inc, RESONANCE HEALTH. These are the top dominating companies in clinical trial imaging market which have maximum number of clinical trial imaging products and receiving large FDA & CE mark approval for launching new products in the market. Data Bridge Market Research new reports highlight the major growth factors and opportunities in the North America clinical trial imaging market.

For More Insights Get FREE Detailed TOC @
https://www.databridgemarketresearch.com/toc/?dbmr=global-clinical-trial-imaging-market&pm

North America Clinical Trial Imaging Market Development

In May 2019, Navitas Life Cycle announces acquisition of KAI Research which strengthens its expertise in pain, diabetes, infectious diseases, and mental health and intends to create an enterprise to deliver and initiate trial outcomes.

Scope of the North America Clinical Trial Imaging Market

North America clinical trial imaging market is segmented on the basis of countries into the U.S., Canada and Mexico. All country based analysis of North America clinical trial imaging market is further analyzed based on further segmentation. On the basis of product & services, the market is segmented into services and software. On the basis of modality, the market is segmented into computed tomography, magnetic resonance imaging, ultrasound, positron emission tomography, X-ray, echocardiography, nuclear medicine, optical coherence tomography and others. On the basis of application, the market is segmented into cardiology, neurology, endocrinology, oncology, dermatology, hematology and others. On the basis of end-user, the market is segmented into contract research organization, pharmaceutical & biotechnology companies, medical device manufacturers, academic and government research institutes and others. On the basis of distributor, the market is segmented into direct sales and tender sales.

Key Pointers Covered in North America Clinical Trial Imaging Market Industry Trends and Forecast to 2026

Market Size
Top to Bottom Market Analysis
Recent Developments for Market Competitors
Recent Market Value for Different Countries

Research Methodology: North America Clinical Trial Imaging Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market time line analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, top to bottom analysis and vendor share analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

Demand Side: Researchers, Scientists, Lab Technicians, Healthcare Professionals, Doctors
Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email @ Corporatesales@databridgemarketresearch.com

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

This release was published on openPR.